Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
LifeMD ( (LFMD) ) has issued an update.
On November 4, 2025, LifeMD, Inc. completed the sale of its majority interest in WorkSimpli Software LLC, valuing the company at approximately $65 million. This strategic divestiture allows LifeMD to focus on expanding its virtual care and pharmacy services, reinforcing its position as a pure-play healthcare company. The transaction, which involved a cash payment of $22 million at closing and potential additional earnings based on performance targets, is expected to strengthen LifeMD’s balance sheet and accelerate growth in its core business areas. The move is seen as a pivotal step in LifeMD’s transformation, enabling the company to concentrate on its primary healthcare offerings and expand into new clinical verticals.
The most recent analyst rating on (LFMD) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on LifeMD stock, see the LFMD Stock Forecast page.
Spark’s Take on LFMD Stock
According to Spark, TipRanks’ AI Analyst, LFMD is a Neutral.
LifeMD’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue growth and high leverage. Technical analysis indicates bearish momentum, further weighing down the score. While the earnings call provided some positive insights, such as telehealth growth and strategic initiatives, these are offset by operational challenges and revised guidance. The valuation remains unattractive due to ongoing losses.
To see Spark’s full report on LFMD stock, click here.
More about LifeMD
LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine, access to laboratory and pharmacy services, and specialized treatment across over 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, a compounding pharmacy, and a U.S.-based patient care center to enhance access to high-quality, affordable care.
Average Trading Volume: 1,523,963
Technical Sentiment Signal: Hold
Current Market Cap: $272.2M
See more insights into LFMD stock on TipRanks’ Stock Analysis page.